𝕏xSE first seen 1 d ago, last 1 d ago, peak #33
Abivax Shares Rise 5% on Obefazimod Praise at UEG Week
Abivax shares climbed around 5% after positive feedback on its lead drug candidate obefazimod at UEG Week, a major European gastroenterology conference. The drug, being developed to treat ulcerative colitis, drew praise from specialists attending the meeting. Investors read the reception as a encouraging signal ahead of the treatment's further development and potential approval.
Why now: New positive expert commentary on obefazimod at UEG Week lifted investor confidence in Abivax stock.
Rank over time, top of the chart is #1. 2 snapshots from 1 d ago to 1 d ago.
API: https://socialmediatrends-api.osmike.com/v1/trends/3015225